INVO Fertility, Inc.
IVF
Positions held
Your positionsIVF isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $3.41M | Enterprise value | $2.44M | Trailing P/E | 0.01 | Forward P/E | -0.09 |
| PEG | — | Price / book | 0.11 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | 16.7% | Earnings growth | — | Gross margin | 35.3% | Operating margin | -59.3% |
| Profit margin | -92.3% | ROE | -72.7% | ROA | -16.4% | Debt / equity | 0.24 |
| Current ratio | 0.71 | Free cash flow | -$5.35M | Analyst recommendation | none | Mean target | $20.00 |
| 52w high | $84.40 | 52w low | $0.71 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $2.2M | $2.0M | $1.6M | $1.8M | $1.9M | — |
| Op margin | -59.3% | -78.9% | -89.2% | -93.1% | -85.5% | — |
| Net income | $0.9M | -$5.5M | $2.0M | -$2.6M | -$3.6M | — |
| Gross margin | 35.1% | 36.1% | 33.9% | 35.8% | 41.3% | — |
| Gross profit | $0.8M | $0.7M | $0.5M | $0.6M | $0.8M | — |
| Operating income | -$1.3M | -$1.6M | -$1.4M | -$1.6M | -$1.6M | — |
- Revenue +8% vs prior quarter ($2.2M vs $2.0M).
- Gross margin 35% (was 36.1% prior quarter).
- Operating margin expanded to -59.3%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $6.8M | $6.5M | $3.0M | $0.8M | — |
| Op margin | -85.4% | -93.6% | -224.0% | -1292.5% | — |
| Net income | -$23.3M | -$9.3M | -$8.0M | -$10.9M | — |
| Gross margin | 37.0% | 44.0% | 36.0% | -3.5% | — |
| Gross profit | $2.5M | $2.9M | $1.1M | -$0.0M | — |
| Operating income | -$5.8M | -$6.1M | -$6.8M | -$10.6M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-25 · INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference
2026-08-28 · INVO Fertility to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
2026-08-17 · INVO Fertility Inc (IVF) (Q2 2026) Earnings Call Highlights: Revenue Surges 17% as Clinic-Level ...
2026-08-17 · INVO Fertility Q2 Revenue Rises 17% as Clinic-Level Profitability Improves
2026-08-17 · BC-Most Active Stocks
2026-08-17 · INVO Fertility Reports Second Quarter 2026 Results Highlighting Revenue Growth and Clinic Platform Profitability
2026-08-17 · Top Premarket Gainers
Price (daily)
Full chart · RSI · MACD · patterns